Merja Soilu-Hänninen
MD, PhD
Turku University Hospital, Division of Clinical Neurosciences mersoi@utu.fi ORCID identifier: https://orcid.org/0000-0001-6930-0229 |
Clinical neurology; neuroimmunology; multiple sclerosis risk factors, prognostic factors and treatment
MD, University of Turku 1988
PhD, University of Turku, Department of Virology, Immunobiology of central nervous system virus infections 1996
Postdoctoral Fellow, Development and Neurobiology Group, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia 1997-1999
Specialist Degree in Neurology 2001
Adjuct Professor of Clinical Neurology 2008
Inverstigator in several clinical MS trials
Chair of the Finnish MS registry 2016-
General Neurology Section Head, Turku University Hospital, Division of Clinical Neurosciences 2017-
Multiple sclerosis risk factors, prognostic factors and epidemiology.
Imaging of brain atrophy in multiple sclerosis.
Course of medical pedagogics 2011-2012
Supervisor of several PhD student
- Exposure to systemic antibiotics in outpatient care and the risk of multiple sclerosis (2023)
- Multiple Sclerosis
(Refereed journal article or data article (A1)) - Proportion and characteristics of secondary progressive multiple sclerosis in five European registries using objective classifiers (2023)
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
(Refereed journal article or data article (A1)) - Real-world treatment outcomes and safety of natalizumab in Finnish multiple sclerosis patients (2023)
- Multiple Sclerosis Journal - Experimental, Translational and Clinical
(Refereed journal article or data article (A1)) - The CLARION study: first report on safety findings in patients newly initiating treatment with cladribine tablets or fingolimod for multiple sclerosis (2023)
- Current Medical Research and Opinion
(Refereed journal article or data article (A1)) - Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study (2022)
- Multiple Sclerosis and Related Disorders
(Refereed journal article or data article (A1)) - Miksi MS-tauti yleistyy? (2022)
- Duodecim
(Refereed review article in scientific journal (A2)) - MS-taudin ja liikehäiriöiden laaturekisterit (2022)
- Erikoislääkäri
(Article in trade journal or blog post (D1)) - Neurosarkoidoosin uudistunut diagnostiikka ja tehostunut hoito (2021)
- Duodecim
(Refereed review article in scientific journal (A2)) - Alemtuzumab is a budget-saving alternative to fingolimod and natalizumab in the treatment of highly active relapsing-remitting multiple sclerosis (2020)
- Dosis
(Refereed journal article or data article (A1)) - Changes in multiple sclerosis epidemiology in Finland over five decades (2020)
- Acta Neurologica Scandinavica
(Refereed review article in scientific journal (A2)) - Lipid Profile Alterations during Fingolimod Treatment in Multiple Sclerosis Patients (2020)
- Journal of Neuroimmune Pharmacology
(Article or data-article in scientific journal (B1)) - Medication adherence/persistence among patients with active multiple sclerosis in Finland (2020)
- Acta Neurologica Scandinavica
(Refereed journal article or data article (A1)) - Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis (2020)
- Frontiers in Neurology
(Refereed journal article or data article (A1)) - Trends and characteristics of infection-related hospital admissions in multiple sclerosis patients in Southwest Finland in 2009–2018 (2020)
- Multiple Sclerosis and Related Disorders
(Refereed journal article or data article (A1)) - Vitamin D supplementation and serum neurofilament light chain in interferon-beta-1b-treated MS patients (2020)
- Brain and Behavior
(Refereed journal article or data article (A1)) - Epstein–barr virus and multiple sclerosis risk in the finnish maternity cohort (2019)
- Annals of Neurology
(Refereed journal article or data article (A1)) - Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004–2014: A retrospective national registry study (2019)
- Journal of the Neurological Sciences
(Refereed journal article or data article (A1)) - MS-tauti ja kognitiivinen toimintakyky (2019)
- Duodecim
(Refereed review article in scientific journal (A2)) - Multiple sclerosis epidemiology in Finland: regional differences and high incidence (2019)
- Acta Neurologica Scandinavica
(Refereed journal article or data article (A1)) - Multiple sclerosis in Finland 2018—Data from the national register (2019)
- Acta Neurologica Scandinavica
(Refereed journal article or data article (A1))